lomustine has been researched along with Abdominal Neoplasms in 4 studies
Abdominal Neoplasms: New abnormal growth of tissue in the ABDOMEN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients older than 1 year with either metastatic or localised stage 2-3 MYCN-amplified neuroblastoma received 2 courses of high-dose topotecan (HD-TPT) 6mg/m(2) and high-dose cyclophosphamide (HD-CPM) 140 mg/kg, followed by 2 courses of ifosfamide, carboplatin and etoposide (ICE) every 28 days." | 7.77 | Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma. ( Castellano, A; De Ioris, MA; De Pasquale, MD; De Vito, R; Donfrancesco, A; Garganese, MC; Ilari, I; Inserra, A; Jenkner, A; Locatelli, F; Natali, G; Ravà, L, 2011) |
| "Nine patients had brain metastases, and seven patients were systemically pretreated." | 6.68 | Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study. ( de Mulder, PH; Jansen, RL; Muller, EW; Punt, CJ; van Herpen, CM; Vreugdenhil, G, 1997) |
| "Patients older than 1 year with either metastatic or localised stage 2-3 MYCN-amplified neuroblastoma received 2 courses of high-dose topotecan (HD-TPT) 6mg/m(2) and high-dose cyclophosphamide (HD-CPM) 140 mg/kg, followed by 2 courses of ifosfamide, carboplatin and etoposide (ICE) every 28 days." | 3.77 | Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma. ( Castellano, A; De Ioris, MA; De Pasquale, MD; De Vito, R; Donfrancesco, A; Garganese, MC; Ilari, I; Inserra, A; Jenkner, A; Locatelli, F; Natali, G; Ravà, L, 2011) |
| "Nine patients had brain metastases, and seven patients were systemically pretreated." | 2.68 | Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study. ( de Mulder, PH; Jansen, RL; Muller, EW; Punt, CJ; van Herpen, CM; Vreugdenhil, G, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Ioris, MA | 1 |
| Castellano, A | 1 |
| Ilari, I | 1 |
| Garganese, MC | 1 |
| Natali, G | 1 |
| Inserra, A | 1 |
| De Vito, R | 1 |
| Ravà, L | 1 |
| De Pasquale, MD | 1 |
| Locatelli, F | 1 |
| Donfrancesco, A | 1 |
| Jenkner, A | 1 |
| Punt, CJ | 1 |
| van Herpen, CM | 1 |
| Jansen, RL | 1 |
| Vreugdenhil, G | 1 |
| Muller, EW | 1 |
| de Mulder, PH | 1 |
| Folke, E | 1 |
| Per, J | 1 |
| Britta, W | 1 |
| Carcavilla, LI | 1 |
| Gómez Perún, J | 1 |
| Alberdi, J | 1 |
| Eiras, J | 1 |
| Arana, T | 1 |
| Pisón, J | 1 |
1 trial available for lomustine and Abdominal Neoplasms
| Article | Year |
|---|---|
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoc | 1997 |
3 other studies available for lomustine and Abdominal Neoplasms
| Article | Year |
|---|---|
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; | 2011 |
Combined therapy with bleomycin against malignant melanomas and testicular tumors.
Topics: Abdominal Neoplasms; alpha-Fetoproteins; Bleomycin; Carcinoembryonic Antigen; Drug Administration Sc | 1976 |
[Abdominal metastasis of a pineal germinoma in a child with a ventriculo-peritoneal shunt].
Topics: Abdominal Neoplasms; Brain Neoplasms; Cerebrospinal Fluid Shunts; Child; Humans; Liver Neoplasms; Lo | 1987 |